AMGN Today - Aug 07: Sales View Boosted by $1B

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

AMGN Today - Aug 07: Sales View Boosted by $1B

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly investor here, breaking down the day for Amgen, or AMGN as the cool kids say. Today was a green day for Amgen, with the stock inching up about 0.34%. Not a massive leap, but hey, we'll take it!

So, what happened? Well, Amgen’s stock got a nice little bump after they announced some big news. They raised their sales outlook by a cool billion bucks! That’s right, they smashed expectations, and that always gets people excited. When a company shows it’s doing better than we thought, investors usually start feeling a bit more optimistic.

Now, why did this happen? The buzz is all about Amgen’s drug growth. They’ve been rolling out some new treatments, and it looks like those are really hitting the mark. Even with some setbacks in the obesity treatment space—yeah, that one stung—they still managed to keep things moving in the right direction. Basically, their performance outpaced those bumps in the road, which is a big deal. Plus, RBC jumped in and raised their price target to $400, so that’s got to feel good for the folks holding the stock.

Oh, and here’s something to keep in mind: the Czech National Bank just grabbed some shares of Amgen. That’s usually a sign that institutional investors are liking what they see, which could mean more confidence in the stock.

So, to wrap it up, Amgen had a solid day, boosted by a raised sales outlook and some positive drug growth news. Always nice to see a company doing well, right? Remember, this is just for your info and entertainment, not financial advice. Catch you later!

まだレビューはありません